HomeCompareBMXXY vs MO

BMXXY vs MO: Dividend Comparison 2026

BMXXY yields 0.79% · MO yields 6.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BMXXY wins by $2.08M in total portfolio value
10 years
BMXXY
BMXXY
● Live price
0.79%
Share price
$12.44
Annual div
$0.10
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.16M
Annual income
$1,739,853.91
Full BMXXY calculator →
MO
Altria Group Inc.
● Live price
6.36%
Share price
$65.99
Annual div
$4.20
5Y div CAGR
22.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$80.1K
Annual income
$30,159.17
Full MO calculator →

Portfolio growth — BMXXY vs MO

📍 BMXXY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBMXXYMO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BMXXY + MO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BMXXY pays
MO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BMXXY
Annual income on $10K today (after 15% tax)
$67.12/yr
After 10yr DRIP, annual income (after tax)
$1,478,875.82/yr
MO
Annual income on $10K today (after 15% tax)
$540.99/yr
After 10yr DRIP, annual income (after tax)
$25,635.29/yr
At 15% tax rate, BMXXY beats the other by $1,453,240.53/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BMXXY + MO for your $10,000?

BMXXY: 50%MO: 50%
100% MO50/50100% BMXXY
Portfolio after 10yr
$1.12M
Annual income
$885,006.53/yr
Blended yield
78.90%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MO right now

BMXXY
No analyst data
Altman Z
7.5
Piotroski
7/9
MO
Analyst Ratings
16
Buy
9
Hold
1
Sell
Consensus: Buy
Price Target
$61.25
-7.2% upside vs current
Range: $47.00 — $68.00
Altman Z
3.2
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BMXXY buys
0
MO buys
0
No recent congressional trades found for BMXXY or MO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBMXXYMO
Forward yield0.79%6.36%
Annual dividend / share$0.10$4.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%22.6%
Portfolio after 10y$2.16M$80.1K
Annual income after 10y$1,739,853.91$30,159.17
Total dividends collected$2.11M$74.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: BMXXY vs MO ($10,000, DRIP)

YearBMXXY PortfolioBMXXY Income/yrMO PortfolioMO Income/yrGap
1← crossover$10,858$157.93$10,570$780.30+$288.00BMXXY
2$11,938$320.51$11,381$1,032.90+$557.00BMXXY
3$13,433$658.71$12,535$1,392.73+$898.00BMXXY
4$15,759$1,385.36$14,193$1,920.91+$1.6KBMXXY
5$19,899$3,037.77$16,618$2,723.68+$3.3KBMXXY
6$28,462$7,170.10$20,263$3,993.80+$8.2KBMXXY
7$49,624$19,169.19$25,936$6,098.36+$23.7KBMXXY
8$115,567$62,469.69$35,166$9,775.01+$80.4KBMXXY
9$395,588$271,931.01$51,026$16,597.78+$344.6KBMXXY
10$2,163,133$1,739,853.91$80,113$30,159.17+$2.08MBMXXY

BMXXY vs MO: Complete Analysis 2026

BMXXYStock

bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems, which use biological samples to diagnose infectious diseases, cardiovascular pathologies, and various cancers; and microbiological testing of manufacturing primarily for food, pharmaceutical, cosmetics, and veterinary sectors. It serves clinical and hospital laboratories, physicians, blood banks, and industrial control laboratories. The company was formerly known as B-D Mérieux. bioMérieux S.A. was founded in 1963 and is headquartered in Marcy l'Etoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.

Full BMXXY Calculator →

MOConsumer Staples

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company provides cigarettes primarily under the Marlboro brand; cigars and pipe tobacco principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. It sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.

Full MO Calculator →
📬

Get this BMXXY vs MO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BMXXY vs SCHDBMXXY vs JEPIBMXXY vs OBMXXY vs KOBMXXY vs MAINBMXXY vs PMBMXXY vs BTIBMXXY vs PG

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.